EDWARD W. HOLMES

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Ilan Katz, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by EDWARD W. HOLMES:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcturus Therapeutics Holdings Inc. Director Common Stock 3,131 $100,286 $32.03 14 Jun 2024 Direct
Arcturus Therapeutics Holdings Inc. Director Deferred Stock Units 0 $0 $32.03 14 Jun 2024 Direct
Arcturus Therapeutics Holdings Inc. Director Stock option (right to buy) 15,000 09 Jun 2025 Direct

Insider Reports Filed by EDWARD W. HOLMES

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARCT Arcturus Therapeutics Holdings Inc. 09 Jun 2025 1 $0 4 Director 11 Jun 2025, 20:00
ARCT Arcturus Therapeutics Holdings Inc. 14 Jun 2024 3 $0 4 Director 18 Jun 2024, 21:01
ARCT Arcturus Therapeutics Holdings Inc. 01 Aug 2023 2 $0 4 Director 03 Aug 2023, 16:11
ARCT Arcturus Therapeutics Holdings Inc. 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 19:15
ARCT Arcturus Therapeutics Holdings Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 18:31